The Company's stock-based compensation plans are described in Note 13, Stock-Based Compensation Plans, to the consolidated financial statements in the 2025 Form 10-K. In general, restricted stock units awarded to executive officers and other employees vest ratably over a period of three years. Subject to the achievement of performance targets established by the Compensation Committee of the Company's Board of Directors (the "Board"), performance stock units vest after a period of three years.

Information for restricted stock units and performance stock units accounted for as equity awards during the six months ended February 28, 2026 is as follows:


	Shares	Weighted Average Fair Value
Outstanding as of August 31, 2025	1,369,205	$	50.37
Granted	752,865	63.91
Vested	(754,967)	48.43
Forfeited	(28,677)	53.75
Outstanding as of February 28, 2026	1,338,426	$	59.01

The Company granted 107,771 equivalent shares in the form of restricted stock units and performance stock units accounted for as liability awards during the six months ended February 28, 2026. As of February 28, 2026, the Company had outstanding 269,157 equivalent shares accounted for under the liability method. The Company expects 257,178 equivalent shares to vest.

Total stock-based compensation expense, including fair value remeasurements, which was primarily included in SG&A expenses in the condensed consolidated statements of earnings (loss), was $14.8 million and $26.0 million for the three and six months ended February 28, 2026, respectively, and was $8.1 million and $18.3 million for the three and six months ended February 28, 2025, respectively.